‫• ﻏﯿﺒﺖ ﻏﯿﺮ ﻣﻮﺟﮫ‬ ‫• ﺣﻀﻮر ﺑﮫ ﻣﻮﻗﻊ و ﺑﺪون ﺗﺎﺧﯿﺮ‬ ‫• ﺧﺎﻣﻮش ﮐﺮدن ﻣﻮﺑﺎﯾﻞ ھﺎ‬ ‫• اﻣﺘﺤﺎن از ﻣﺒﺎﺣﺚ ﮐﻼﺳﯽ و ﮐﺘﺎب رﻓﺮاﻧﺲ‬ ‫• ﺗﺎرﯾﺦ اﻣﺘﺤﺎن ﻣﯿﺎن ﺗﺮم روی ﻃﺮح درس‬

Pharmacodynamics M Rabbani Ph.D. Department of Pharmacology Isfahan University of Medical Sciences

94 ‫ﻣﻬﺮ‬

[email protected]

1

Lecture Objectives    

2

What is pharmacodynamics?

Pharmacodynamics definition Drug targets Agonists / Antagonists Affinity

[email protected]

[email protected]

Dose

3

Effect site Concentration

Effect

Pharmacokinetics

Pharmacodynamics

Absorption Distribution Metabolism Elimination Drug interactions

Tissue/organ sensitivity (target status) It is the study of biochemical and physiological effects of drug and their mechanism of action at organ level as well as cellular level.

[email protected]

4

Drug targets

Drugs Drugs can be defined as chemical agents that uniquely interact with specific target molecules in the body, thereby producing a biological effect.

[email protected]

5

[email protected]

6

1

BOUND WITH WHAT ?

Question  A drug will not work unless it is bound  AGREED or NOT AGREED

[email protected]

7

PARTICULAR CONSTITUENTS OF CELLS & TISSUES IN ORDER TO PRODUCE AN EFFECT    

8

ARE THERE DRUGS THAT ACT WITHOUT BEING BOUND TO ANY OF THE TISSUE CONSTITUENTS?

PROTEINS LIPIDS DNA Else

YES OR

NO

[email protected]

9

YES    

[email protected]

[email protected]

10

Most drugs act by binding to a target molecule

OSMOTIC DIURETICS OSMOTIC PURGATIVES ANTACIDS HEAVY METALS CHELATING AGENTS

[email protected]

11

[email protected]

12

2

Drug targets: enzymes 1. In patients (Captopril Captopril,, ACE inhibitors,) 2. In microbes (Penicillins Penicillins,, inhibit transpeptidase) 3. In cancer cells (55-FU, inhibits thymidilate synthase)

TARGET BIOMOLECULES: 1. 2. 3. 4.

ENZYMES ION CHANNELS TRANSPORTERS RECEPTORS

[email protected]

13

[email protected]

14

Drug targets: ion channels Ca: Verapamil Na: Lidocaine K : Sulfonlyurea Cl: Lubiprostone

[email protected]

15

[email protected]

Drug targets: transporters

16

Receptors

Na/K ATPase: cardiac glycosides

 Usually a protein

[email protected]

 Definition: macromolecule or binding site located on cell surface or inside the effecter cell that serves to recognize the signal molecule/drug and initiate the response to it, but itself has no other function

17

[email protected]

18

3

Receptor Families

Drug targets: receptors    

Most drugs act on receptors in or on cells Form tight bonds with the ligand Size, shape, stereospecificity Can be agonists (salbutamol), or antagonists (propranolol)

[email protected]

19

A- Ligand-gated ion channels

A

B

C

D

[email protected]

20

B. G-protein coupled receptor systems  Have three components: the recptor recptor,, G protein, effector effector..

• Specific for certain ions

•When ligand binds, channel opens allowing ions to flow either inward or outward

 LigandLigand-bound domain is located in a pocket accessible from the cell surface

• Response extremely fast

 Response rapid

[email protected]

21

[email protected]

22

23

[email protected]

24

G protein-linked receptors

[email protected]

4

C- Enzyme linked  Span full width of membrane  Ligand binding domain is external and catalytic binding region is on inside of membrane  Response within seconds.

[email protected]

25

D- Transcription Factors

[email protected]

26

Transcription Factors

 Found within the cell (on DNA in nucleus)  Regulate protein synthesis through RNA synthesis  Eg Eg.. steroids receptors  Responses are delayed (hours to days)

[email protected]

27

[email protected]

28

Agonists  Agonists:  Full  Partial  Inverse

 Antagonist

[email protected]

29

[email protected]

30

30

5

Agonist

Agonist

 Agonist: An agent which activates a receptor to produce an effect similar to a that of the physiological signal molecule, e.g. Muscarine Increase or decrease the effect

[email protected]

31

Agonist: molecules that activate receptors (mimicry)

[email protected]

32

Agonist Inactivation (Depression) – decrease the rate of functional activity (ß2 in lung)

ß1 in heart

+ [email protected]

33

[email protected]

34

Full vs Partial  Inverse agonist: an agent which activates receptors to produce an effect in the opposite direction to that of the agonist, e.g. DMCM  Ligand: any molecule which attaches selectively to particular receptors or sites (only binding or affinity)

[email protected]

35

[email protected]

36

6

Intrinsic activity

Inverse agonist

 Ability of a drug to activate its receptor.  High intrinsic activity relates to high maximal efficacy  2 drugs can bind to same # of receptors with different intensities of response

[email protected]

37

‫آﻧﺘﺎﮔﻮﻧﯿﺴﺖ‬

[email protected]

38

Antagonist

‫ ﺟﻠﻮﮔﯿﺮی از ﭘﯿﻮﻧﺪ اﮔﻮﻧﯿﺴﺖ ﯾﺎ ﻣﻮاد اﻧﺪوژن ﺑﺎ رﺳﭙﺘﻮر‬ ‫ اﻓﯿﻨﯿﺘﯽ ﺑﺎﻻ ﺑﺮای رﺳﭙﺘﻮر اﻣﺎ ﺑﺪون اﻓﯿﮑﺎﺳﯽ ﯾﺎ ﻓﻌﺎﻟﯿﺖ زاﺗﯽ‬ :‫ ﺗﻘﺴﯿﻢ ﺑﻨﺪی آﻧﺘﺎﮔﻮﻧﯿﺴﺖ‬ ‫آﻧﺘﺎﮔﻮﻧﯿﺴﺖ ھﺎی ﻓﺎرﻣﺎﮐﻮﻟﻮژﯾﮏ‬ ‫آﻧﺘﺎﮔﻮﻧﯿﺴﺖ ھﺎی ﻓﯿﺰﯾﻮﻟﻮژﯾﮏ‬ ‫آﻧﺘﺎﮔﻮﻧﯿﺴﺖ ھﺎی ﻓﺎرﻣﺎﮐﻮﮐﯿﻨﺘﯿﮏ‬ ‫آﻧﺘﺎﮔﻮﻧﯿﺴﺖ ھﺎی ﺷﯿﻤﯿﺎﯾﯽ‬

    Blocking – prevents an action or respons

[email protected]

39

[email protected]

40

[email protected]

42

‫آﻧﺘﺎﮔﻮﻧﯿﺴﺖ ھﺎی ﻓﺎرﻣﺎﮐﻮﻟﻮژﯾﮏ‬ ‫ رﻗﺎﺑﺘﯽ ﯾﺎ ﺑﺮﮔﺸﺖ ﭘﺬﯾﺮ‬ ‫ ﻏﯿﺮ رﻗﺎﺑﺘﯽ ﯾﺎ ﺑﺮﮔﺸﺖ ﻧﺎﭘﺬﯾﺮ‬

[email protected]

41

41

7

‫آﻧﺘﺎﮔﻮﻧﯿﺴﺖ ﻓﯿﺰﯾﻮﻟﻮژﯾﮏ‬

‫آﻧﺘﺎﮔﻮﻧﯿﺴﺖ ﻓﺎرﻣﺎﮐﻮﮐﯿﻨﺘﯿﮏ‬

‫ آﺛﺎر ﻣﺘﻀﺎد دو دارو در ﺑﺪن‬ ‫ ﺑﺎ ﺗﺎﺛﯿﺮ ﺑﺮ دو ﻧﻮع ﮔﯿﺮﻧﺪه‬ ‫ اﺛﺮ ھﯿﺴﺘﺎﻣﯿﻦ و اﻣﭙﺮازول‬

[email protected]

43

43

‫ ﺑﺎ ﻣﮑﺎﻧﯿﺴﻢ ھﺎی ﻣﺘﻔﺎوت ﻏﻠﻈﺖ ﯾﮏ دارو را در ﺑﺪن ﮐﺎھﺶ ﻣﯽ‬ ‫دھﻨﺪ‬ ‫ ﻓﻨﻮﺑﺎرﺑﯿﺘﺎل و وارﻓﺎرﯾﻦ‬

[email protected]

44

44

‫آﻧﺘﺎﮔﻮﻧﯿﺴﺖ ﺷﯿﻤﯿﺎﺋﯽ‬ ‫ اﺛﺮ ﺷﻼﺗﮫ ﮐﻨﻨﺪه دی ﻣﺮﮐﺎﭘﺮول ﺑﺮروی ﻓﻠﺰات ﺳﻨﮕﯿﻦ‬ Heparin, an anticoagulant, acidic If there is too much  bleeding and haemorrhaging Protamine sulfate is a base. It forms a stable inactive complex with heparin and inactivates it.

[email protected]

[email protected]

45

45

[email protected]

46

47

8

Dynamic-1.pdf

HEAVY METALS CHELATING AGENTS. [email protected] 12. Most drugs act ... itself has no other function. Page 3 of 8. Dynamic-1.pdf. Dynamic-1.pdf.

2MB Sizes 3 Downloads 239 Views

Recommend Documents

No documents